CHEK2 and type 2 diabetes mellitus: Using a recently developed kinase prediction model, we demonstrate that the impaired changes in T2D phosphorylation mapped to pathways regulated by AKT2 and potential changes in PKCθ, CHK2, PHKG2, and STK32C.